Top

Published in:

01-06-2011 | Original Article

Results of medical treatment and metabolic risk factors in children with urolithiasis

Authors: Metin Kaya Gürgöze, Mehmet Yusuf Sarı

Published in: Pediatric Nephrology | Issue 6/2011

Abstract

Data on conservative treatment in children with urolithiasis are limited. The aim of the study was to determine the metabolic etiology and results of conservative treatment in children with urolithiasis. We evaluated the clinical presentation and metabolic features of 112 children with urolithiasis. The mean age at diagnosis of urolithiasis was 3.9 (range 0.1–18) years, and follow-up duration was 16.7 (range 1–36) months. The most common presenting symptoms were flank or abdominal pain and restlessness (25%). Urine analysis revealed metabolic abnormalities in 92% of cases, including hypocitraturia (42%), hyperoxaluria (32.1%), hypercalcuria (25%), hyperuricosuria (9.8%), and cystinuria (2.7%). Patients who had metabolic risk factors were treated according to underlying metabolic abnormalities. About half of these patients were stone free or stones were diminished in size. These results showed that early recognition and treatment of urinary metabolic abnormalities will reduce the number of invasive procedures and renal damage in children with urolithiasis.

Goldfarb DS (2003) Increasing prevalence of kidney stones in the United States. Kidney Int 63:1951–1952CrossRef

VanDervoot K, Wiesen J, Frank R, Vento S, Crosby V, Chadra M, Trachtman H (2007) Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 177:2300–2305CrossRef

Remzi D, Çakmak F, Erkan I (1980) A study on urolithiasis incidence in school age children. J Urol 123:608–610CrossRef

Sirin A, Emre S, Alpay H, Nayir A, Bilge I, Tanman F (1995) Etiology of chronic renal failure in Turkish children. Pediatr Nephrol 9:549–552CrossRef

Turkey National Hemodialysis (2004) Transplantation and Nephrology Registry Report of Turkey 2003. Istanbul. Available at: https://doi.org/www.tsn.org.tr/registry/Registry_2003_Tr_Eng.pdf

Erbagci A, Erbagci AB, Yılmaz M, Yagci F, Trakcioglu M, Yurtseven C, Koyluoglu O, Sarica K (2003) Pedaitric urolithiasis evaluation of risk factors in 95 children. Scand J Urol Nephrol 37:129–133CrossRef

Bak M, Ural R, Agin H, Serdaroglu E, Calkavur S (2009) The metabolic etiology of urolithiasis in Turkish children. Int Urol Nephrol 41:453–460CrossRef

Cameron MA, Sakhaee K, Moe OW (2005) Nephrolithiasis in children. Pediatr Nephrol 20:1587–1592CrossRef

Polito C, Cioce F, La Manna A, Maiello R, Di Torro R (1999) Renal calyceal microlithiasis: clinical presentation may precede sonographic evidence. Clin Pediatr (Phila) 38:521–524CrossRef

10.

Alon US (2009) Medical treatment of pediatric urolithiasis. Pediatr Nephrol 24:2129–2135CrossRef

11.

Alpay H, Ozen A, Gokce I, Biyikli N (2009) Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol 24:2203–2209CrossRef

12.

Ozkutan BH, Küçükaydın M, Gündüz Z, Kabaklioğlu M, Okur H, Turan C (2000) Urolithiasis in childhood. Pediatr Surg Int 16:60–63CrossRef

13.

Oner A, Demircin G, İpekcioğlu H, Bulbul M, Ecin N (1997) Etiological and clinical patterns of urolithiasis in Turkish children. Eur Urol 31:453–458CrossRef

14.

Perrone HC, Santos DR, Santos MV, Pinherio ME, Toporovski J, Ramos OL, Schor N (1992) Urolithiasis in childhood: metabolic evaluation. Pediatr Nephrol 6:54–56CrossRef

15.

Gerhart JP, Herzberg GZ, Jeffs RD (1991) Chilhood urolithiasis: experience and advances. Paediatrics 87:445–450

16.

Hari P, Bagga A, Vasudev V, Singh M, Srivastava RN (1995) Aetiology of nephrolithiasis in north Indian children. Pediatr Nephrol 9:474–475CrossRef

17.

Dursun I, Poyrazoglu MH, Düşünsel R, Gündüz Z, Gürgöze MK, Demirci D, Küçükaydın M (2008) Pediatric urolithiasis: an 8-year experience of single center. Int Urol Nephrol 40:3–9CrossRef

18.

Hulton SA (2001) Evaluation of urinary tract calculi in children. Arch Dis Child 84:320–323CrossRef

19.

Tefekli A, Esen T, Ziylan O, Erol B, Armağan A, Ander H, Akıncı M (2000) Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int 459:1–10

20.

Kalorin CM, Zabinski A, Okpareke I, White M, Kogan BA (2009) Pediatric urinary stones disease-does age matter? J Urol 181:2267–2271CrossRef

21.

Spivacow FR, Negri AL, del Valle EE, Calvino I, Zanchetta JR (2009) Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol 42:471–475CrossRef

22.

Tekin A, Tekgül S, Atsu N, Bakkaloglu M, Kendi S (2002) Oral potassium citrate treatment for idiopathic hypocitraturia in children with calcium urolithiasis. J Urol 168:2572–2574CrossRef

23.

Sarica K (2006) Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment. Urol Res 34:96–101CrossRef

Title: Results of medical treatment and metabolic risk factors in children with urolithiasis
Authors: Metin Kaya Gürgöze
Mehmet Yusuf Sarı
Publication date: 01-06-2011
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 6/2011
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-011-1803-3

At a glance: The STEP trials

Springer Medicine

Results of medical treatment and metabolic risk factors in children with urolithiasis

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2011

In memoriam: Professor Niilo Oskar Birger Hallman, July 15, 1916 – January 13, 2011

Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?

Pericardial tamponade in a child with nephrotic syndrome

Growth of kidney-transplanted pediatric patients treated with sirolimus

Medication beliefs and perceived barriers in adolescent renal transplant patients and their parents

Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome